The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Run-off Property-Liability; Protection Services; Allstate Health and Benefits; and Corporate and Other. The company offers private passenger auto, homeowners, personal lines, and commercial insurance products through agents, contact centers, and online; and property and casualty insurance products. It also provides consumer product protection plans, device and mobile data collection services, and analytic solutions using automotive telematics information, roadside assistance, and protection plans; and insurance products, such as identity protection and restoration through Allstate Protection Plans, Allstate Dealer Services, Allstate Roadside, Arity, and Allstate Identity Protection brands. In addition, the company offers life, accident, critical illness, hospital indemnity, short-term disability, and other health insurance products; self-funded stop-loss and fully insured group health products to employers; medicare supplement, ancillary products, and short-term medical insurance to individuals through independent agents, owned agencies, benefits brokers, and Allstate exclusive agents. Further, it offers automotive protection; vehicle service contracts, guaranteed asset protection, road hazard tires and wheels, and paintless dent repair protection; and roadside assistance, mobility data collection services, and analytic solutions using automotive telematics information, identity theft protection, and remediation services. The Allstate Corporation was founded in 1931 and is headquartered in Northbrook, Illinois.

Allstate Corporation (The)

Macquarie analyst maintained a Buy rating on Aristocrat Leisure today and set a price target of A$75.00. In addition to Macquarie, Aristocrat Leisu...

Macquarie Sticks to Its Buy Rating for Aristocrat Leisure  (ARLUF)

Jefferies analyst maintained a Buy rating on Ball today and set a price target of $64.00. In addition to Jefferies, Ball also received a Buy from T...

Jefferies Keeps Their Buy Rating on Ball (BALL)

In a report released yesterday, Robert Burns from H.C. Wainwright reiterated a Buy rating on Allogene Therapeutics, with a price target of $8.00. T...

Allogene Therapeutics (ALLO) Receives a Buy from H.C. Wainwright

Allot ( ($ALLT) ) has provided an announcement. On November 4, 2025, Allot Ltd. announced it will hold its Annual General Meeting of Shareholders o...

Allot Ltd. Schedules Annual General Meeting for December 2025

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Allogene Therapeutics (ALLO – Research Report), Neur...

Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO), NeurAxis, Inc. (NRXS) and Celcuity (CELC)

Citi analyst Adrian Lemme maintained a Buy rating on Aristocrat Leisure today and set a price target of A$71.00. According to TipRanks, Lemme is a ...

Citi Keeps Their Buy Rating on Aristocrat Leisure  (ARLUF)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Allogene Therapeutics (ALLO – Research Report), Ha...

Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO), Halozyme (HALO) and Progyny (PGNY)

Oppenheimer analyst Matthew Biegler reiterated a Buy rating on Allogene Therapeutics yesterday and set a price target of $7.00. Biegler covers the ...

Allogene Therapeutics (ALLO) Gets a Buy from Oppenheimer

Cantor Fitzgerald analyst Ryan Tunis maintained a Hold rating on Allstate yesterday and set a price target of $202.00. Tunis covers the Financial s...

Allstate (ALL) Receives a Hold from Cantor Fitzgerald

Analysts have been eager to weigh in on the Financial sector with new ratings on Ally Financial (ALLY – Research Report) and OneMain Holdings (OMF ...

Analysts Offer Insights on Financial Companies: Ally Financial (ALLY) and OneMain Holdings (OMF)

Morgan Stanley analyst Melinda Baxter maintained a Buy rating on Aristocrat Leisure today and set a price target of A$73.70. The company’s shares c...

Morgan Stanley Keeps Their Buy Rating on Aristocrat Leisure  (ARLUF)

Barclays analyst Julian Mitchell maintained a Hold rating on Allegion today and set a price target of $187.00. The company’s shares closed yesterda...

Barclays Reaffirms Their Hold Rating on Allegion (ALLE)

Mizuho Securities analyst Brett Linzey maintained a Hold rating on Allegion yesterday and set a price target of $170.00. The company’s shares close...

Mizuho Securities Reaffirms Their Hold Rating on Allegion (ALLE)

Morgan Stanley analyst Bob Huang maintained a Buy rating on Allstate today and set a price target of $245.00. The company’s shares closed yesterday...

Morgan Stanley Keeps Their Buy Rating on Allstate (ALL)

There’s a lot to be optimistic about in the Financial sector as 2 analysts just weighed in on Huntington Bancshares (HBAN – Research Report) and Al...

Analysts Are Bullish on Top Financial Stocks: Huntington Bancshares (HBAN), Ally Financial (ALLY)

Analysts fell to the sidelines weighing in on Morgan Stanley (MS – Research Report) and Ally Financial (ALLY – Research Report) with neutral rating...

Analysts Offer Insights on Financial Companies: Morgan Stanley (MS) and Ally Financial (ALLY)

Analysts Are Bullish on These Financial Stocks: Huntington Bancshares (HBAN), Ally Financial (ALLY)

Wells Fargo Remains a Hold on Allegion (ALLE)

Analysts have been eager to weigh in on the Financial sector with new ratings on State Street (STT – Research Report), Ally Financial (ALLY – Resea...

Analysts Offer Insights on Financial Companies: State Street (STT), Ally Financial (ALLY) and Fifth Third Bancorp (FITB)

The latest announcement is out from Atlantic Lithium ( ($GB:ALL) ). Atlantic Lithium has announced significant lithium-in-soil anomalies within its...

Atlantic Lithium Uncovers Significant Lithium Anomalies in Côte d’Ivoire

KBW analyst Meyer Shields maintained a Buy rating on Allstate today and set a price target of $246.00. The company’s shares closed yesterday at $19...

KBW Keeps Their Buy Rating on Allstate (ALL)

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Par Technology (PAR – Research Report) and Allot (AL...

Analysts Are Bullish on These Technology Stocks: Par Technology (PAR), Allot (ALLT)

Ball received a Hold rating and price target from Raymond James analyst today. The company’s shares closed today at $47.55. The word on The Street ...

Ball (BALL) Initiated with a Hold at Raymond James

In a report released today, Tomohiko Sano from J.P. Morgan maintained a Buy rating on Allegion, with a price target of $190.00. The company’s share...

Allegion (ALLE) Receives a Buy from J.P. Morgan

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Ally Financial (ALLY – Research Report) and Invesco...

Mkt Cap	$50.91B	Price	$207.36
Volume	919.63K	Change	+1.70%
P/E Ratio	10.9	Open	$204.87
Revenue	$64.1B	Prev Close	$203.89
Net Income	$4.7B	52W Range	$176.00 - $215.70
Div Yield	4.00%	Target	$234.75
Overall	74	Value	100
Quality	60	Technical	63

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ALL	$207.36	+1.70%	919.63K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ALL	$207.36	+1.7%	919.63K
3
4
5
6

ALL

ALL

Company Overview

Latest News

Macquarie Sticks to Its Buy Rating for Aristocrat Leisure (ARLUF)

Jefferies Keeps Their Buy Rating on Ball (BALL)

Allogene Therapeutics (ALLO) Receives a Buy from H.C. Wainwright

Allot Ltd. Schedules Annual General Meeting for December 2025

Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO), NeurAxis, Inc. (NRXS) and Celcuity (CELC)

Get Allstate Corporation (The) Data in Excel

Get Allstate Corporation (The) Data in Excel